Medcenter One Health Systems, 222 N 7th St, Bismark, ND 58501, USA.
Am J Public Health. 2010 Jan;100(1):13-7. doi: 10.2105/AJPH.2008.147629.
Hepatitis C in prison populations is now a major public health problem, and large numbers of correctional facilities have no comprehensive management program, often because of formidable projected costs and tightening budget constraints. The North Dakota Department of Corrections and Rehabilitation has operated a management and therapy program since 2002 using consensus interferon and ribavirin with 45% cost savings. The program has provided excellent sustained viral responses: 54.2% for genotype 1 hepatitis C, 75% for genotypes 2 and 3, and 63.6% overall.
监狱人群中的丙型肝炎现在是一个主要的公共卫生问题，许多惩教设施没有全面的管理方案，这往往是因为预计费用巨大和预算紧张。北达科他州惩教和康复部自 2002 年以来一直使用共识干扰素和利巴韦林实施管理和治疗方案，节省了 45%的成本。该方案提供了极好的持续病毒应答率：基因型 1 丙型肝炎为 54.2%，基因型 2 和 3 为 75%，总体为 63.6%。
